After radical surgery, the lower expression of MMP14 had significant effects on the prognosis of tumors, including ACC, BLCA, BRCA, GBM, KIRC, LGG, LIHC, MESO, OV, PAAD, THCA (Thyroid carcinoma), and uveal melanoma (UVM). Here, MMP14 is linked to glioblastoma.